Solstein Capital’s DarioHealth DRIO Stock Holding History

Solstein Capital’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-104	Closed	-$44K	–	473
2021 Q2	$44K	Sell	104 -126	-55%	-$48K	0.05%	226
2021 Q1	$89K	Buy	+230	New	+$104K	0.12%	159

Other funds holding DRIO

CHM

Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Solstein Capital's DRIO Position: Q3 2021 in Review

Solstein Capital sold out of DarioHealth (DRIO) in Q3 2021, closing a stake of 104 shares — an estimated $44K sold.

Solstein Capital first reported a position in DRIO in Q1 2021 and held it in 2 quarters. The position peaked at $89K in Q1 2021. 57 funds tracked by Wall St. Rank hold DRIO as of Q3 2021.

Solstein Capital reported no remaining DarioHealth position as of Q3 2021 after selling out during the quarter.
Solstein Capital sold 104 DarioHealth shares in Q3 2021, an estimated $44K.
Solstein Capital first reported a position in DarioHealth in Q1 2021 and held it in 2 quarters.
Solstein Capital's DarioHealth position peaked at $89K in Q1 2021.
57 funds tracked by Wall St. Rank held DarioHealth as of Q3 2021.

Based on Solstein Capital's 13F filing for Q3 2021, filed 27 Oct 2021.